{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:36:35Z","timestamp":1786649795895,"version":"build-2736575974"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Sacubitril\/valsartan (angiotensin receptor-neprilysin inhibitor [ARNI]) is widely used to manage heart failure, a common complication in patients with cyanotic congenital heart disease (CCHD). Its effects on the kidneys, especially in patients with long-standing cyanosis, remain poorly understood. We report three cases of CCHD who were started on ARNI for ventricular dysfunction. During treatment, all three developed features of cyanotic nephropathy. The discontinuation of ARNI led to a gradual improvement in renal function in all cases. This highlights a possible correlation between the use of ARNI and compromised renal parameters in patients with CCHD. Further studies are necessary to evaluate the renal safety and long-term effects of ARNI therapy.<\/jats:p>","DOI":"10.4103\/apc.apc_252_25","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T13:00:07Z","timestamp":1767272407000},"page":"388-391","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Effects of sacubitril\/valsartan, an angiotensin receptor-neprilysin inhibitor, on renal impairment in patients with cyanotic congenital heart disease"],"prefix":"10.4103","volume":"18","author":[{"given":"Kavyasree","family":"Kandukuri","sequence":"first","affiliation":[{"name":"Department of Pediatric Cardiology, Apollo Institute of Medicine Sciences and Research, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwa Mohan","family":"Kasi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Apollo Institute of Medicine Sciences and Research, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Maheshwari","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Apollo Institute of Medicine Sciences and Research, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Apollo Institute of Medicine Sciences and Research, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,1]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1002\/ehf2.13378","article-title":"Heart failure related to adult congenital heart disease: Prevalence, outcome and risk factors","volume":"8","author":"Arnaert","year":"2021","journal-title":"ESC Heart Fail"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00467-017-3804-3","article-title":"Prevalence and associated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease","volume":"33","author":"Hongsawong","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40560-017-0251-y","article-title":"Practical approach to detection and management of acute kidney injury in critically ill patient","volume":"5","author":"Mohsenin","year":"2017","journal-title":"J Intensive Care"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nefro.2018.05.001","article-title":"A case report of cyanotic nephropathy","volume":"39","author":"Ortega-D\u00edaz","year":"2019","journal-title":"Nefrologia"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jacbts.2022.05.010","article-title":"Neprilysin inhibitors in heart failure: The science, mechanism of action, clinical studies, and unanswered questions","volume":"8","author":"Bozkurt","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2169\/internalmedicine.8373-21","article-title":"Acute tubular necrosis associated with angiotensin receptor-neprilysin inhibitor","volume":"61","author":"Kim","year":"2022","journal-title":"Intern Med"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/2150135119825599","article-title":"Early experience with sacubitril\/valsartan in adult patients with congenital heart disease","volume":"10","author":"Lluri","year":"2019","journal-title":"World J Pediatr Congenit Heart Surg"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1007\/s00246-025-03973-8","article-title":"Single-center experience with sacubitril\/valsartan in patients with congenital heart disease","volume":"46","author":"Konduri","year":"2025","journal-title":"Pediatr Cardiol"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000538100","article-title":"Cyanotic nephropathy in an adult patient with Eisenmenger syndrome: A case report and literature review","volume":"49","author":"Zhu","year":"2024","journal-title":"Kidney Blood Press Res"}],"container-title":["Annals of Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/apc.apc_252_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:58:27Z","timestamp":1786647507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/apc.apc_252_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/apc.apc_252_25","relation":{},"ISSN":["0974-2069","0974-5149"],"issn-type":[{"value":"0974-2069","type":"print"},{"value":"0974-5149","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2025-09-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}